Navigation Links
To combat deadly brain cancer, target the stem cells
Date:7/7/2011

Researchers have uncovered a new target that could stop the growth of glioblastoma, a deadly form of brain cancer. In the July 8th issue of the journal Cell, a Cell Press publication, a new study identifies an enzyme found in glioma stem cells that allows them to grow and seed tumors. Importantly, normal stem cells, including those in the brain, don't appear to share that same dependency.

"When thinking about therapeutics [targeting cancer stem cells], you have to be careful that you aren't interfering with normal stem cells," said Christine Eyler of the Cleveland Clinic. "Glioma stem cells are not derived from normal stem cells but they do share many features with them. The trick to therapy is to find pathways exhibited only by cancer stem cells."

The goal of Eyler's team, led by Cleveland Clinic scientist Jeremy Rich, was to identify just such a pathway in glioma stem cells, a particularly devastating form of brain cancer. Despite modern surgical and medical therapies, those diagnosed with a glioblastoma have a median survival of just over a year.

Previous work identifying glioma cells with stem-cell like behavior and demonstrating the propagation of gliomas in animals offered hope for the development of anti-glioma therapeutics. The challenge, however, has been finding pathways that differ between glioma and normal stem cells in spite of evidence that the glioma stem cells closely resemble embryonic and neural stem cells.

Earlier studies led the researchers to investigate the pathway that produces nitric oxide (NO), a molecule thought to support tumors' growth and resistance to treatment. Those experiments showed that glioma cells express varying levels of nitric oxide synthases, critical enzymes in that pathway.

"It's important to note that there are different forms of nitric oxide synthases," said Anita Hjelmeland, also at the Cleveland Clinic. "We focused on one that is well restricted to glioma stem cells."

In the current study, the authors use mouse models of glioma to show that glioma stem cells have elevated levels of nitric oxide synthase-2 (NOS2). This leads to exess production of NO, which, in turn, endows stem cells with the ability to growand seed tumors.

These findings have real clinical relevance, the researchers say. They found that high NOS2 levels correlate with decreased survival in patients with glioma. Moreover, treatments designed to block NOS2 in the brain slow the growth of brain tumors in mice.

Notably, NOS2 inhibitors have already been tested in clinical trials for other treatments. "The exciting part is the drugs have already been given to people," Eyler said, and it appears they have little toxicity.

NOS2 inhibitors could be a welcome addition to therapies in use for gliomas today. "If you target the tumor as a whole, you may get rid of most cells but leave the stem cells behind," Hjelmeland said. But if you only target cancer stem cells and leave the rest intact, tumors may continue to grow. By combining approaches, "you'll have a better therapy."

Eyler said she wouldn't be surprised if the nitric oxide pathway uncovered in glioma stem cells might also prove to be important in other forms of cancer. The researchers also continue to look for other pathways unique to cancer stem cells.


'/>"/>

Contact: Elisabeth Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related medicine news :

1. Video games may help combat depression in older adults
2. National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics
3. SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria
4. Combat E-Cigarette in Demand by Civilians
5. The Net Impact Creates Website for St. Louis Event to Combat the Stigma of Mental Illness
6. HIV Drugs Might Combat Two Other Diseases
7. Children of combat-deployed parents show increased worries, even after parent returns
8. HealthMETRICS Partners, Inc. Article in AJMC Outlines Innovative Approach to Combat Rising Healthcare Costs
9. Holistic Management and Allan Savory Win the 2010 Buckminster Fuller Award for Turning Deserts into Thriving Grasslands and Combating Climate Change.
10. Novel Drug Combats Advanced Melanoma
11. US Army 2010 Combat Casualty Care Conference, Aug. 16-19, St. Pete Beach, Fla.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... ... July 23, 2017 , ... A 20-year-long study by a ... by the Minneapolis Veterans Administration Health Care System overwhelmingly supports growing evidence that prostate ... few benefits. , In the cases involved with this study, surgery did not ...
(Date:7/23/2017)... LA (PRWEB) , ... July 23, 2017 , ... ... to interact, thus improving communication, safety and patient-provider relationships. New tools are helping ... to results of the 19th Annual Health Care’s Most Wired® survey, released today ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a leading medical ... No. 9,038,640 by the United States Patent and Trademark Office. The patent applies ... Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and safety of ...
(Date:7/21/2017)... ... ... "As a doctor of lung medicine managing chest diseases for more than two ... inventor from Center Valley, Pa. "My idea is to improve the device to a ... PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means of draining pleural fluid from ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... assistance and financial planning services to families and business owners in northern Florida, ... that promises to provide support to area adults with developmental challenges. , The ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... BOTHELL, Wash. , July 5, 2017   ... a leading developer, manufacturer and marketer of proprietary clinical ... cryopreservation freeze media ("BioLife"), today announced that ... ("WAVI") its debt holder and largest shareholder, to modify ... Pursuant to the modification, WAVI agreed to ...
(Date:6/30/2017)... 2017  AVACEN Medical (AVACEN) announced the publication of new research ... use of its AVACEN Treatment Method to significantly reduce ... ... Medical ... It affects approximately 200 to 400 million people worldwide according to ...
(Date:6/27/2017)... --  NuEyes (NuEyes Technologies Inc.) today announced that it ... in helping the legally blind live more independent lives. NuEyes works ... developer of augmented, virtual and mixed reality smartglasses and the ... funding amount was provided by strategic partners as well as ... Abu Dhabi , New York ...
Breaking Medicine Technology: